Next-generation anti-TL1A antibody(Telavant)

N/A

Report date: 2023/08/24 17:29:45

Base Information

Drug NameNext-generation anti-TL1A antibody(Telavant)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionTumor necrosis factor superfamily member 15 inhibitors
TargetsTumor necrosis factor superfamily member 15
Therapy Area/IndicationsInflammationFibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTelavant Inc
China Registration ClassN/A

Develop Information

Active CompaniesTelavant Inc
Inactive CompaniesN/A
Active IndicationsInflammationFibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A